Vivos Therapeutics Inc — Quarterly Cash Flow (NASDAQ:VVOS) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Total assets 15.35 M15.28 M11.28 M26.03 M25.64 M Total liabilities 7.7 M7.3 M6.9 M21.5 M23.1 M Total equity 7.67 M7.95 M4.41 M4.58 M2.53 M Total liabilities & shareholders' equities 15.35 M15.28 M11.28 M26.03 M25.64 M Total debt ————— Net debt —————

Notizie

Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Certara (NASDAQ:CERT), Vivos Therapeutics (NASDAQ:VVOS)

Vivos Therapeutics 4,64 milyon dolarlık hisse senedi alım hakkı anlaşmasını duyurdu

Vivos Therapeutics announces $4.64 million warrant exercise deal

Vivos Therapeutics (VVOS) Upgraded to Buy: Here's What You Should Know

Vivos Therapeutics, Inc. (VVOS) Discusses Strategic Business Model Pivot and Transition in Sleep Apnea Treatment Approach Transcript

Vivos, Michigan’da yeni uyku merkezini açarak ulusal varlığını genişletiyor

Vivos opens new sleep center in Michigan, expanding national footprint

Vivos Therapeutics, Inc. (VVOS) Q3 2025 Earnings Call Transcript

Earnings call transcript: Vivos Therapeutics Q3 2025 shows revenue growth

Vivos kazancı $0,01 ile beklentilere göre daha kötü, kâr ise beklentilere göre yüksek

Vivos earnings missed by $0.01, revenue topped estimates

This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Adverum Biotechnologies (NASDAQ:ADVM), Alto Neuroscience (NYSE:ANRO)